Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, ORIC Pharmaceuticals Inc (NASDAQ: ORIC) closed at $10.71 down -2.99% from its previous closing price of $11.04. In other words, the price has decreased by -$2.99 from its previous closing price. On the day, 0.88 million shares were traded. ORIC stock price reached its highest trading level at $11.31 during the session, while it also had its lowest trading level at $10.535.
Ratios:
For a deeper understanding of ORIC Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.00 and its Current Ratio is at 12.00. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ladenburg Thalmann on July 08, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
On October 31, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $20.
On September 06, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $20.Stifel initiated its Buy rating on September 06, 2024, with a $20 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 01 ’25 when Piscitelli Dominic sold 20,000 shares for $10.05 per share. The transaction valued at 200,972 led to the insider holds 48,317 shares of the business.
Piscitelli Dominic sold 32,466 shares of ORIC for $341,039 on Jun 24 ’25. The Chief Financial Officer now owns 68,317 shares after completing the transaction at $10.50 per share. On Jun 23 ’25, another insider, Piscitelli Dominic, who serves as the Chief Financial Officer of the company, sold 1,034 shares for $10.00 each. As a result, the insider received 10,344 and left with 100,783 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 912689088 and an Enterprise Value of 566346368.
Stock Price History:
The Beta on a monthly basis for ORIC is 1.70, which has changed by 0.009425044 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, ORIC has reached a high of $14.67, while it has fallen to a 52-week low of $3.90. The 50-Day Moving Average of the stock is 11.65%, while the 200-Day Moving Average is calculated to be 26.58%.
Shares Statistics:
For the past three months, ORIC has traded an average of 1.35M shares per day and 1749080 over the past ten days. A total of 71.08M shares are outstanding, with a floating share count of 42.35M. Insiders hold about 50.31% of the company’s shares, while institutions hold 69.99% stake in the company. Shares short for ORIC as of 1752537600 were 12290002 with a Short Ratio of 9.12, compared to 1749772800 on 12712072. Therefore, it implies a Short% of Shares Outstanding of 12290002 and a Short% of Float of 14.63.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
